Dopamine transporter endocytic determinants: Carboxy terminal residues critical for basal and PKC-stimulated internalization

被引:53
作者
Boudanova, Ekaterina [2 ]
Navaroli, Deanna M. [2 ]
Stevens, Zachary [1 ]
Melikian, Haley E. [1 ,2 ,3 ]
机构
[1] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA
[2] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA
关键词
Reuptake; Transporter; Moncamine; Trafficking; Endocytosis;
D O I
10.1016/j.mcn.2008.06.011
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Dopamine (DA) reuptake terminates dopaminergic neurotransmission and is mediated by DA transporters (DATs). Acute protein kinase C (PKC) activation accelerates DAT internalization rates, thereby reducing DAT surface expression. Basal DAT endocytosis and PKC-stimulated DAT functional downregulation rely on residues within the 587-596 region, although whether PKC-induced DAT downregulation reflects transporter endocytosis mechanisms linked to those controlling basal endocytosis rates is unknown. Here, we define residues governing basal and PKC-stimulated DAT endocytosis. Alanine substituting DAT residues 587-590 1) abolished PKC stimulation of DAT endocytosis, and 2) markedly accelerated basal DAT internalization, comparable to that of wildtype DAT during PKC activation. Accelerated basal DAT internalization relied specifically on residues 588-590, which are highly conserved among SLC6 neurotransmitter transporters. Our results Support a model whereby residues within the 587-590 stretch may serve as a locus For a PKC-sensitive braking mechanism that tempers basal DAT internalization rates. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 41 条
[1]
Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[2]
Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions [J].
Bjerggaard, C ;
Fog, JU ;
Hastrup, H ;
Madsen, K ;
Loland, CJ ;
Javitch, JA ;
Gether, U .
JOURNAL OF NEUROSCIENCE, 2004, 24 (31) :7024-7036
[3]
Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent [J].
Boudanova, Ekaterina ;
Navaroli, Deanna A. ;
Melikian, Haley E. .
NEUROPHARMACOLOGY, 2008, 54 (03) :605-612
[4]
Functional imaging studies on dopamine and motor control [J].
Brooks, DJ .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (11) :1283-1298
[5]
Restoration of the striatal dopamine synthesis for Parkinson's disease:: Viral vector-mediated enzyme replacement strategy [J].
Carlsson, Thomas ;
Bjorklund, Tomas ;
Kirik, Deniz .
CURRENT GENE THERAPY, 2007, 7 (02) :109-120
[6]
Carneiro AM, 2002, J NEUROSCI, V22, P7045
[7]
Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter [J].
Carneiro, Ana Marin D. ;
Blakely, Randy D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (34) :24769-24780
[8]
Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6 [J].
Chen, NH ;
Reith, MEA ;
Quick, MW .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :519-531
[9]
Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter [J].
Chen, Rong ;
Tilley, Michael R. ;
Wei, Hua ;
Zhou, Fuwen ;
Zhou, Fu-Ming ;
Ching, San ;
Quan, Ning ;
Stephens, Robert L. ;
Hill, Erik R. ;
Nottoli, Timothy ;
Han, Dawn D. ;
Gu, Howard H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) :9333-9338
[10]
Treatment of psychosis: 30 years of progress [J].
De Oliveira, I. R. ;
Juruena, M. F. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (06) :523-534